| MR编号 | FR/V/0237/001 |
|---|
| 药品名称 | CANIGEN DHPPi/L |
|---|
| 活性成分 | - canine adenovirus 4.0 log10 CCID50
- canine distemper virus 3.15 log10 CCID50
- canine parainfluenza virus 5.0 log10 CCID50
- canine parvovirus 5.0 log10 CCID50
- leptospira interrogans serogroup canicola 8.33 8log10 bact/mL
- leptospira interrogans serogroup icterohaemorragiae 8.33 8log10 bact/mL
|
|---|
| 剂型 | Powder and solvent for suspension for injection |
|---|
| 上市许可持有人 | VIRBAC |
|---|
| 参考成员国 - 产品名称 | France (FR) CANIGEN DHPPi/L |
|---|
| 互认成员国 - 产品名称 | - Germany (DE)
Canigen DHPPi/L - Denmark (DK)
- Belgium (BE)
Canigen DHPPi/L - Netherlands (NL)
- Luxembourg (LU)
- Ireland (IE)
- Austria (AT)
- Spain (ES)
- Portugal (PT)
- Italy (IT)
- Greece (GR)
- Sweden (SE)
- Bulgaria (BG)
- Cyprus (CY)
- Estonia (EE)
- Finland (FI)
- Croatia (HR)
- Lithuania (LT)
- Latvia (LV)
Canigen DHPPi/L - Norway (NO)
- Poland (PL)
- Romania (RO)
- Slovenia (SI)
- Slovakia (SK)
- Czechia (CZ)
- United Kingdom (Northern Ireland) (XI)
Canigen DHPPi/L - Hungary (HU)
|
|---|
| 许可日期 | 2011/12/16 |
|---|
| 最近更新日期 | 2023/12/14 |
|---|
| 药物ATC编码 | - QI07AI02 live canine distemper virus + live canine adenovirus + live canine parainfluenza virus + live canine parvovirus + inactivated leptospira
| 申请类型 | - TypeLevel1：[not specified]
- TypeLevel2：[not specified]
- TypeLevel3：Full dossier - art 12.3 Dir 2001/82/EC
- TypeLevel4：[not specified]
- TypeLevel5：[not specified]
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|